Tissuemed announces TissuePatch™ approval in China
Tissuemed Ltd (Leeds, UK) has been granted regulatory approval of its TissuePatch™ range of ultra-thin surgical sealant films by the Chinese FDA (‘CFDA’).
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160601005413/en/
TissuePatch™ is the first and only synthetic sealant to be approved by the CFDA , giving Tissuemed sole access to a significant medical device market that is being driven by both an increase in income and a population greater than 1 billion, aging faster than any other country. Sales of medical devices in China have increased rapidly over the last decade, exceeding £30 billion in 2015.
The approval comes at the end of an exhaustive two and a half year programme and importantly covers all surgical applications for TissuePatch sealant film technology, allowing Tissuemed to extend its product reach beyond the traditional Neuro and Thoracic spaces.
Speaking about CFDA approval, Tissuemed’s CEO David Mandley said, ‘Approval of TissuePatch™ in China marks a major achievement for the company. This success opens the door to a significant market and is an exciting phase in the commercialisation of our innovative product range. With regulatory requirements in China becoming ever more challenging this approval is testament to Tissuemed’s proven technology and robust Quality System.’
‘We have a commercial partner in China with a proven track record of successfully introducing innovative products to address the demands of a rapidly growing healthcare system. Chinese surgeons will now be able to use our unique self-adhesive sealant film to prevent leaks after surgery, reducing post-operative complications and the need for extended hospital stay.’
For further information visit www.tissuemed.com
Dr David Mandley
+44 (0)113 2000500
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
SD-SAB-BIOTHERAPEUTICS15.8.2018 19:45 | pressemeddelelse
Ebola Successfully Neutralized by Latest Generation Polyclonal Immunotherapy
NV-RIMINI-STREET,-INC.15.8.2018 19:07 | pressemeddelelse
Rimini Street Receives Asia-Pacific Stevie Award for Customer Service Innovation
INSTITUTE-BIOTECHNOLOGY15.8.2018 15:05 | pressemeddelelse
2018 Healthcare+ Expo Taiwan: Where Tech Meets Medicine
CA-QUAKE-GLOBAL15.8.2018 15:02 | pressemeddelelse
QConnect - The Most Intelligent, Global, Ultra-Compact, Rugged Communication Device
PA-PEI-GENESIS15.8.2018 13:09 | pressemeddelelse
PEI-Genesis Names Kris Haggstrom Senior Director of E-Commerce and EMS
CA-QUANERGY-SYSTEMS15.8.2018 12:02 | pressemeddelelse
Quanergy Signs Oprema as Distribution Partner for UK and Ireland
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum